DrugPatentWatch Database Preview

Drugs in Development Information for Patritumab

« Back to Dashboard

Summary for Patritumab

US Patents	6
International Patents	149
US Patent Applications	0
WIPO Patent Applications	0
Japanese Patent Applications	0
Clinical Trial Progress	Phase 1 (2014-03-01)
Vendors	0

US Patents for Patritumab

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Patritumab		Multispecific constructs	AbbVie Stemcentrx LLC (North Chicago, IL)
Patritumab		Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein	CureVac AG (Tubingen, DE)
Patritumab		P97 fragments with transfer activity	biOasis Technologies, Inc. (Vancouver, British Columbia, unknown)
Patritumab		Fragments of p97 and uses thereof	biOasis Technologies, Inc. (Richmond, CA)
Patritumab		Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein	CureVac AG (Tubingen, DE)
Patritumab		Anti-CD324 monoclonal antibodies and uses thereof	ABBVIE STEMCENTRX LLC (North Chicago, IL)

International Patents for Patritumab

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Patritumab	Canada	2900764	2033-02-08
Patritumab	European Patent Office	2954056	2033-02-08
Patritumab	Hong Kong	1218930	2033-02-08
Patritumab	Japan	2016509014	2033-02-08
Patritumab	World Intellectual Property Organization (WIPO)	2014124326	2033-02-08
Patritumab	Australia	2012294673	2031-08-05
Patritumab	Canada	2842492	2031-08-05